European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading

MT Newswires Live11-10 00:13

European equities traded in the US as American depositary receipts kicked off the week on a strong note late Monday morning, surging 2.17% to 1,894.38 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS (FOCL) and telecommunications company Nokia (NOK), which climbed 11.5% and 7.8% respectively. They were followed by lenders Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which rose 5% and 4.1% respectively.

The decliners from continental Europe were led by biotech firm Evaxion (EVAX) and accommodations booking site trivago (TRVG), which lost 6.5% and 1.1% respectively. They were followed by petroleum refiner Equinor (EQNR) and biotech firm BioNTech (BNTX), which dropped 1.8% and 0.3% respectively.

The gainers from the UK were led by biopharmaceutical companies Mereo BioPharma Group (MREO) and Bicycle Therapeutics (BCYC), which advanced 5.2% and 3.6% respectively. They were followed by insurance company Prudential (PUK) and mining company BHP Group (BHP), which increased 4.4% and 3.4% respectively.

The decliners from the UK and Ireland were led by software firm Endava (DAVA) and biotech firm Trinity Biotech (TRIB), which fell 4.3% and 5.3% respectively. They were followed by medical device maker Smith & Nephew (SNN) and tobacco company British American Tobacco (BTI), which were down 1.2% and 1.3% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment